News
MHRA grants marketing authorisation for Novartis’ Pluvicto
Advanced Accelerator Applications – a Novartis company – has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation in Britain for Pluvicto.